Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18677977 | 1.00 | KDM1A (0.52) | KDM1AHPGDMGAMSIKMT2A | |
| SCHEMBL18677909 | 1.00 | KDM1A (0.52) | KDM1AHPGDMGAMSIKMT2A | |
| SCHEMBL17345949 | 1.00 | KDM1A (0.52) | KDM1AHPGDMGAMSIKMT2A | |
| SCHEMBL18663232 | 0.89 | KDM1A (0.59) | KDM1AHPGDMGAMSIKMT2A | |
| SCHEMBL2830909 | 0.78 | L3MBTL1 (0.58) | KDM1AHPGDMGAMSIKMT2A | |
| SCHEMBL5863472 | 0.77 | L3MBTL1 (0.60) | KDM1AHPGDKMT2AMEN1POLB | |
| SCHEMBL9457203 | 0.77 | CYP3A4 (0.52) | HPGDKMT2AMEN1POLBTSHR | |
| SCHEMBL9457200 | 0.77 | CYP3A4 (0.52) | HPGDKMT2AMEN1POLBTSHR | |
| SCHEMBL2719923 | 0.74 | KDM1A (0.54) | KDM1AHPGDMGAMSIKMT2A | |
| SCHEMBL8038053 | 0.73 | KDM1A (0.50) | KDM1AHPGDKMT2AMEN1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170088571-A1 | POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS | TRIAD NATIONAL SECURITY, LLC | 2017-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170088571-A1 | POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS | NANS, NCL, NCLN | KDM1A 4774/4885HPGD 973/4885MGAM 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.